阮 淼, 水若鸿. The clinicopathologic factors associated with nipple-areola complex involvement in breast cancer[J]. China Oncology, 2016, 26(5): 361-366. DOI: 10.3969/j.issn.1007-3969.2016.05.001.
The clinicopathologic factors associated with nipple-areola complex involvement in breast cancer
Nipple-areola complex-sparing mastectomy (NSM) is a surgical procedure that allows the preservation of the skin and nipple-areola complex (NAC) in mastectomy. The use of NSM for breast cancer is still controversial. The appropriate standard for selecting patients with low risk of NAC involvement has not been well established. The clinicopathologicity characteristics of primary tumor (e.g.
tumor-to-nipple distance
tumor location
tumor size
multicentricity
lymph node metastasis
lymphovascular invasion
grade
HER-2 status) have been reported to be associated with NAC involvement. Clinical evaluation of NAC
retroareolar tissue biopsy and evaluation of clinicopathologic characteristics of primary tumor are helpful to patient selection in current clinical practice of NSM. Further studies are still needed to establish uniform selection criteria for NSM in breast cancer patients.
The role of radiotherapy in nipple-areola complex-sparing mastectomy for patients with breast cancer
Guidelines for breast cancer diagnosis and treatment by China Anti-Cancer Association (2026 edition)
Progress and prospects of CENPA-driven chromosomal instability in breast cancer: mechanisms, prognostic implications, and therapeutic perspectives
A study of 30-year trends in incidence and mortality risks of breast cancer among young women in China
Impact of miR-193a-3p on migration and invasion of breast cancer stem cells through targeting TRIM14
Related Author
俞晓立
郭小毛
The Society of Breast Cancer China Anti-Cancer Association
Breast Oncology Group of the Oncology Branch of the Chinese Medical Association
LU Ye
ZHANG Wenxiang
KONG Xiangyi
FANG Yi
Related Institution
复旦大学附属肿瘤医院放射治疗中心,复旦大学上海医学院肿瘤学系
Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital& Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Department of Cancer Prevention, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University
Shanghai Engineering Research Center of Artificial Intelligence Technology for Tumor Diseases